Jump to Main Content
Differential reduction of reactive oxygen species by human tissue-specific mesenchymal stem cells from different donors under oxidative stress
- Paliwal, Swati, Kakkar, Anupama, Sharma, Rinkey, Airan, Balram, Mohanty, Sujata
- Journal of biosciences 2017 v.42 no.3 pp. 373-382
- adipose tissue, antimycin A, bone marrow, cardiomyocytes, clinical trials, coculture, humans, medicine, oxidative stress, reactive oxygen species, stem cells, tooth pulp, umbilical cord
- Clinical trials using human Mesenchymal Stem Cells (MSCs) have shown promising results in the treatment of various diseases. Different tissue sources, such as bone marrow, adipose tissue, dental pulp and umbilical cord, are being routinely used in regenerative medicine. MSCs are known to reduce increased oxidative stress levels in pathophysiological conditions. Differences in the ability of MSCs from different donors and tissues to ameliorate oxidative damage have not been reported yet. In this study, for the first time, we investigated the differences in the reactive oxygen species (ROS) reduction abilities of tissue-specific MSCs to mitigate cellular damage in oxidative stress. Hepatic Stellate cells (LX-2) and cardiomyocytes were treated with Antimycin A (AMA) to induce oxidative stress and tissue specific MSCs were co-cultured to study the reduction in ROS levels. We found that both donor’s age and source of tissue affected the ability of MSCs to reduce increased ROS levels in damaged cells. In addition, the abilities of same MSCs differed in LX-2 and cardiomyocytes in terms of magnitude of reduction of ROS, suggesting that the type of recipient cells should be kept in consideration when using MSCs in regenerative medicine for treatment purposes.